Tumor-promoting functions of transforming growth factor-β in progression of cancer

References

• Moses HL, Roberts AB. The discovery of TGF-β: a historical perspective. The TGF-β family. New York: Cold Spring Harbor Laboratory Press; 2009. p. 1–28.
   Google Scholar
• Roberts AB, Wakefield LM. The two faces of transforming growth factor-β in carcinogenesis. Proc Natl Acad Sci USA. 2003;100:8621–3.
   PubMed Web of Science ®Google Scholar
• Ikushima H, Miyazono K. TGF-β signalling: a complex web in cancer progression. Nat Rev Cancer. 2010;10:415–24.
   PubMed Web of Science ®Google Scholar
• Sanchez-Capelo A. Dual role for TGF-β1 in apoptosis. Cytokine Growth Factor Rev. 2005;16:15–34.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465–71.
   PubMed Web of Science ®Google Scholar
• Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem. 2010;147:35–51.
   PubMed Web of Science ®Google Scholar
• Koinuma D, Tsutsumi S, Kamimura N, Taniguchi H, Miyazawa K, Sunamura M, Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling. Mol Cell Biol. 2009;29:172–86.
   PubMed Web of Science ®Google Scholar
• Koinuma D, Tsutsumi S, Kamimura N, Imamura T, Aburatani H, Miyazono K. Promoter-wide analysis of Smad4 binding sites in human epithelial cells. Cancer Sci. 2009;100:2133–42.
   PubMed Web of Science ®Google Scholar
• Mizutani A, Koinuma D, Tsutsumi S, Kamimura N, Morikawa M, Suzuki HI, Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4α in HepG2 cells. J Biol Chem. 2011;286:29848–60.
   PubMed Web of Science ®Google Scholar
• Kamiya Y, Miyazono K, Miyazawa K. Smad7 inhibits transforming growth factor-β family type I receptors through two distinct modes of interaction. J Biol Chem. 2010;285:30804–13.
   PubMed Web of Science ®Google Scholar
• Deheuninck J, Luo K. Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res. 2009;19:47–57.
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin CH. Non-Smad TGF-β signals. J Cell Sci. 2005;118:3573–84.
   PubMed Web of Science ®Google Scholar
• Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 2007;26:3957–67.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.
   PubMed Web of Science ®Google Scholar
• Sabe H. Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor-β signalling. J Biochem. 2011;149:633–9.
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119:1429–37.
   PubMed Web of Science ®Google Scholar
• Miyazono K. Transforming growth factor-β signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:314–23.
   PubMed Web of Science ®Google Scholar
• Shirakihara T, Horiguchi K, Miyazawa K, Ehata S, Shibata T, Morita I, TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J. 2011;30:783–95.
   Google Scholar
• Itoh N, Ornitz DM. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem. 2011;149:121–30.
   PubMed Web of Science ®Google Scholar
• Horiguchi K, Sakamoto K, Koinuma D, Semba K, Inoue A, Inoue S, TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene. 2011 Oct 31 (Epub ahead of print).
   Google Scholar
• Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J. 2010;29:3286–30.
   PubMed Web of Science ®Google Scholar
• Horiguchi K, Shirakihara T, Nakano A, Imamura T, Miyazono K, Saitoh M. Role of Ras signaling in the induction of snail by transforming growth factor-β. J Biol Chem. 2009;284:245–53.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells. Cell Tissue Res. 2011 May 31 (Epub ahead of print).
   Google Scholar
• Minoo P, Su G, Drum H, Bringas P, Kimura S. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1-/- mouse embryos. Dev Biol. 1999;209:60–71.
   PubMed Web of Science ®Google Scholar
• Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450:893–8.
   PubMed Web of Science ®Google Scholar
• Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 2011;473:101–4.
   PubMed Web of Science ®Google Scholar
• Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res. 2009;69:2783–91.
   PubMed Web of Science ®Google Scholar
• Minoo P, Hu L, Zhu N, Borok Z, Bellusci S, Groffen J, SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains. Nucleic Acids Res. 2008;36:179–88.
   Google Scholar
• Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537–49.
   PubMed Web of Science ®Google Scholar
• Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor β signaling. J Natl Cancer Inst. 2009;101:592–604.
   PubMedGoogle Scholar
• Johansson E, Komuro A, Iwata C, Hagiwara A, Fuse Y, Watanabe A, Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma. Cancer Sci. 2010;101:2398–403.
   PubMed Web of Science ®Google Scholar
• Watabe T, Nishihara A, Mishima K, Yamashita J, Shimizu K, Miyazawa K, TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol. 2003;163:1303–11.
   PubMed Web of Science ®Google Scholar
• Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K. Snail is required for TGF-β-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci. 2008;121:3317–24.
   PubMed Web of Science ®Google Scholar
• Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008;133:66–77.
   PubMed Web of Science ®Google Scholar
• Yang YA, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects. J Clin Invest. 2002;109:1607–15.
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Wakabayashi Y, Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-β. J Biochem. 2010;147:781–92.
   PubMed Web of Science ®Google Scholar
• Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P. The polarization of immune cells in the tumour environment by TGF-β. Nat Rev Immunol. 2010;10:554–67.
   PubMed Web of Science ®Google Scholar
• Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, An anti-transforming growth factor-β antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res. 2008;68:3835–43.
   PubMed Web of Science ®Google Scholar
• Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst. 2005;97:1734–46.
   PubMedGoogle Scholar
• Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M, Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res. 2007;67:9694–703.
   PubMed Web of Science ®Google Scholar
• Li Y, Xie M, Yang J, Yang D, Deng R, Wan Y, The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple Sp1 binding sites in the proximal promoter. Oncogene. 2006;25:3296–306.
   PubMed Web of Science ®Google Scholar
• Hoshino Y, Katsuno Y, Ehata S, Miyazono K. Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim. J Biochem. 2011;149:55–65.
   PubMed Web of Science ®Google Scholar
• Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest. 1999;103:197–206.
   PubMed Web of Science ®Google Scholar
• Deckers M, van Dinther M, Buijs J, Que I, Lowik C, van der Pluijm G, The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 2006;66:2202–9.
   PubMed Web of Science ®Google Scholar
• Ehata S, Hanyu A, Fujime M, Katsuno Y, Fukunaga E, Goto K, Ki26894, a novel transforming growth factor-β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci. 2007;98:127–33.
   PubMed Web of Science ®Google Scholar
• Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K. Autocrine TGF-β signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell. 2009;5:504–14.
   PubMed Web of Science ®Google Scholar
• Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I, TGF-β increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell. 2009;15:315–27.
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–15.
   PubMed Web of Science ®Google Scholar
• Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010;463:676–80.
   PubMed Web of Science ®Google Scholar
• Ferletta M, Caglayan D, Mokvist L, Jiang Y, Kastemar M, Uhrbom L, Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells. Int J Cancer. 2011;129:45–60.
   PubMed Web of Science ®Google Scholar
• Anido J, Saez-Borderias A, Gonzalez-Junca A, Rodon L, Folch G, Carmona MA, TGF-β receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell. 2010;18:655–68.
   PubMed Web of Science ®Google Scholar
• Ehata S, Johansson E, Katayama R, Koike S, Watanabe A, Hoshino Y, Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene. 2011;30:1693–705.
   PubMed Web of Science ®Google Scholar
• Tang B, Yoo N, Vu M, Mamura M, Nam JS, Ooshima A, Transforming growth factor-β can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res. 2007;67:8643–52.
   PubMed Web of Science ®Google Scholar
• Morikawa M, Koinuma D, Tsutsumi S, Vasilaki E, Kanki Y, Heldin CH, ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res. 2011;39:8712–27.
   Google Scholar